NOW Thai HAART Study

Completed

• Conditions: HIV; AIDS; Neurological Complications

• Registration Number: NCT00367731
• Lead Sponsor: Rajavithi Hospital

Brief Summary

After Initiation of HAART in peoples who living with HIV/AIDS in Thailand by the year 2000, rapidly expanded HAART access of national project has been promoted in 2004. Free ARVs (For CD4\<200cell/cu.mm. or in symptomatic HIV with CD4\<250 cell/cu.mm. )and CD4 monitoring has been available. The first-line regimen is d4T+3TC+NVP in mainly the first time (Naive) patients. CD4 response ), rate of opportunistic infection, and neurological outcomes were measured. Rate of ARV change, adverse events,treatment failure, TB co-infection rate, percent changing to EFV-based regimen or PI-based regimen were recorded.

Any Adverse Events including, Sever rash, Severe Hepatitis, Lipid abnormalities, Severe Anemia and Other, common AEs will be analysed.

Detailed Description

Not available

Study Timeline

• Study Start: 2005-01
• Status Verified: 2006-08
• Study First Submitted: 2006-08-22
• Study First Submitted QC: 2006-08-22
• Last Update Submitted: 2006-08-22
• Study First Posted: 2006-08-23
• Last Update Posted: 2006-08-23
• Study Completion: 2006-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

• HIV/AIDS patients.
• Age >15 years.
• informed consent

Exclusion Criteria

• Not informed consent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (3)

Rajavithi Hospital; 🇹🇭 Bangkok, Thailand

Lumpang Hospital; 🇹🇭 Lumpang, Thailand

Sappasithiprasong Hospital; 🇹🇭 Ubonratchathani, Thailand